-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-09
Wang et al. (2024) identify the METTL16-SENP3-LTF signaling axis as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). This work uncovers a new molecular pathway linking m6A RNA modification, iron metabolism, and cell death, offering new targets for the development of ferroptosis-sensitizing therapies.
-
5-Aminolevulinic acid HCl: Empowering Heme Biosynthesis Assa
2026-05-08
5-Aminolevulinic acid HCl (5-ALA HCl) stands out as a highly soluble, rigorously quality-controlled intermediate for heme biosynthesis, enabling advanced research into immune evasion and photodynamic applications. Explore workflow enhancements, troubleshooting insights, and the translational power of APExBIO’s gold-standard reagent.
-
Macrophage EV-Encapsulated miR-660 Drives Breast Cancer Meta
2026-05-08
This study reveals that extracellular vesicles (EVs) derived from tumor-associated macrophages deliver microRNA-660 (miR-660) to breast cancer cells, promoting metastasis by downregulating KLHL21 and activating the NF-κB p65 pathway. The findings identify a novel intercellular signaling mechanism that shapes tumor progression and highlight potential targets for intervention in metastatic breast cancer.
-
BFH772 (VEGFR2 inhibitor): Technical Guidance and Workflow S
2026-05-07
BFH772 is a highly selective VEGFR2 inhibitor designed for precise modulation of VEGFR2-mediated angiogenesis, particularly in tumor model systems. It is suited for workflows requiring high kinase selectivity and compatibility with organic solvents, but should not be used in assays demanding water solubility or broad-spectrum kinase inhibition.
-
Angiotensin III: Workflow-Driven Advances in RAAS Peptide Re
2026-05-07
Angiotensin III (human, mouse) empowers cardiovascular and neuroendocrine research with high-purity, workflow-compatible performance as a pressor and aldosterone modulator. This article translates the latest mechanistic insights and protocol optimizations into actionable steps for bench scientists—bridging classic RAAS studies with emerging cross-domain models.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-06
Wang et al. reveal that the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and promotes tumor progression in hepatocellular carcinoma. Their work uncovers a mechanistic link between m6A RNA modification and iron metabolism, providing new directions for therapeutic intervention.
-
Honokiol in Quantitative Drug Response: Precision in Cancer
2026-05-06
Explore how Honokiol, a potent NF-κB pathway inhibitor, enables rigorous, quantitative assessment of drug response in modern cancer research. This article uniquely bridges in vitro assay design with mechanistic insight and experimental reproducibility.
-
Troxerutin Inhibits Mitochondrial Fission in Diabetic Cognit
2026-05-05
This study demonstrates that troxerutin ameliorates diabetic cognitive dysfunction in mice by inhibiting TRPM7-mediated mitochondrial fission via the CaN/Drp1ser637 pathway. The findings reveal a novel mechanism underlying neuroprotection in diabetes-associated cognitive impairment and identify TRPM7 as a promising therapeutic target.
-
Bradykinin (BA5201): Technical Guide for Vascular Research
2026-05-05
Bradykinin (BA5201) enables precise modeling of endothelium-dependent vasodilation and vascular permeability modulation in cardiovascular, pain, and inflammation-related research. This product should be used in controlled experimental workflows and is not intended for diagnostic or clinical applications. Stringent solution handling and storage protocols are essential to maintain peptide stability and reproducibility.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-05-04
This study demonstrates that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin III, enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide mechanistic insights into the possible contribution of the renin–angiotensin–aldosterone system (RAAS) to viral entry and COVID-19 pathogenesis.
-
Calpeptin: Potent Calpain Inhibitor for Fibrosis Research
2026-05-04
Calpeptin is a nanomolar calpain inhibitor used to modulate cell differentiation, fibrosis, and inflammation. It demonstrates efficacy in suppressing pro-fibrotic mediators in vitro and in vivo, supporting its utility in pulmonary fibrosis research. This article details Calpeptin’s biochemical rationale, mechanism, key evidence, and practical workflow integration.
-
CD28-ARS2 Axis Orchestrates PKM Splicing for CD8+ T Cell Imm
2026-05-03
This study uncovers a CD28-ARS2 signaling axis that drives alternative splicing of pyruvate kinase (PKM) in CD8+ T cells, promoting metabolic flexibility vital for antitumor immunity. The findings clarify how costimulatory signaling shapes T cell metabolism and function, offering new perspectives for immunometabolic research.
-
Sunitinib as a Precision Tool for Functional RTK Pathway Pro
2026-05-02
Explore how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, enables precise functional profiling of RTK signaling and apoptosis in cancer research. This article uniquely examines actionable assay decisions and ATRX-deficient model insights for advanced oncology applications.
-
HotStart™ 2X Green qPCR Master Mix: Practical Guide & Protoc
2026-05-01
HotStart™ 2X Green qPCR Master Mix resolves key challenges in SYBR Green-based real-time PCR, including non-specific amplification and poor reproducibility, through antibody-mediated Taq polymerase inhibition. It is best suited for gene expression analysis, nucleic acid quantification, and RNA-seq validation workflows using qPCR. This reagent is not recommended for probe-based detection chemistries or applications requiring direct multiplexing with non-SYBR dyes.
-
Angiotensin 1/2 (1-6): Precision Tool for Vascular & Renal A
2026-05-01
Angiotensin 1/2 (1-6) is a uniquely potent hexapeptide for dissecting vascular tone and renal signaling, standing apart from conventional angiotensin fragments. Its robust solubility, mechanistic specificity, and translational relevance empower advanced cardiovascular and viral pathogenesis research.